Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving Surgery

Clinical trial NCT07723469 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07723469
Sponsor: SURGE Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

TNBC - Triple-Negative Breast Cancer

Start date: 2026-10-01
Primary completion: 2034-10-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.